Please Wait
Applying Filters...
menu
    • menu
    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    Data Compilation
    #PharmaFlow

    Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

    Stock Recap
    #PipelineProspector

    Menu

    Everolimus

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 272,439Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    27/09/2025 Biocon
    India
    		 Biocon Limited 307MF10060 Everolimus (0.2% BHT) 2025-05-14 2025-05-14 20th KM Hosur Road, Electronics City, Bengaluru-560 100, Karnataka, India.
    27/09/2025 BrightGene Bio-Medical Technology Co.,Ltd
    China
    		 BrightGene Pharmaceutical Co. , Ltd. 230MF10023 Everolimus 2018-02-14 2018-10-23 Building C25-C28, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China 215123